Apie programą
Europos Komisijos kvietimai
Tarptautiniai renginiai
Partnerių paieška
Dalyvavimo statistika
Nemokamos konsultacijos
Parama rengti paraiškas
Parama susitikti konsorciumams
Parama ieškoti partnerių
Prizai

Inovatyvios medicinos iniciatyva – IMI2

Konsultuoja teminės srities atstovė, NCP: Edita Bagdonaitė, edita.bagdonaite@mita.lt

Kvietimo identifikatorius ir pavadinimas

Finansavimo schemos kodas

Kvietimo paskelbimo data 

Paraiškos priimamos iki
(pirmojo/antrojo etapo paraiškų priėmimo data, jei taikoma dviejų pakopų schema)

IMI2-2017-13-01: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-02: Genome-Environment Interactions in Inflammatory Skin Disease

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-03: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-04: Mitochondrial Dysfunction in Neurodegeneration

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-05: Support and coordination action for the projects of the Neurodegeneration area of the Innovative Medicines Initiative

CSA

2017-11-30

(2018-02-28/2018-09-06)


IMI2-2017-13-06: A sustainable European induced pluripotent stem cell platform

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-07: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-08: Human Tumour Microenvironment Immunoprofiling

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-09: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now

RIA

2017-11-30

(2018-02-28/2018-09-06)


IMI2-2017-13-10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases

RIA

2017-11-30

(2018-02-28/2018-09-06)

IMI2-2017-13-15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases

RIA

2017-11-30

(2018-02-28/2018-09-06)


© MOKSLO, INOVACIJŲ IR TECHNOLOGIJŲ AGENTŪRA, VALSTYBĖS BIUDŽETINĖ ĮSTAIGA. DUOMENYS KAUPIAMI IR SAUGOMI JURIDINIŲ ASMENŲ REGISTRE.
A. GOŠTAUTO 12-219, LT-01108 VILNIUS. TEL. +370 (5) 2644708; FAKSAS +370 (5) 2312292; EL. PAŠTAS Šis el. pašto adresas yra apsaugotas nuo šiukšlių. Jums reikia įgalinti JavaScript, kad peržiūrėti jį.